US · EMN · CHEMICALS - SPECIALTY
Eastman Chemical Company (EMN) intrinsic value and stock valuation
$58.77as of 2026-11-21 · Mkt cap 8.42B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Eastman Chemical Company DCF and intrinsic value
InvestorsCraft values EMN with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from EMN’s statements →
Eastman Chemical Company Graham Number
Graham Number: $69.96d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Ternium S.A. (TX) $45.85
- Gerdau S.A. (GGB) $4.16
- Element Solutions Inc (ESI) $29.52
- Iamgold Corporation (IAG) $14.44
- Axalta Coating Systems Ltd. (AXTA) $34.12
- NewMarket Corporation (NEU) $697.47
- Sasol Limited (SSL) $11.52
- Eagle Materials Inc. (EXP) $172.25
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.2B | $10.5B | $10.5B |
| Operating income | $931M | $1.38B | $1.1B | $1.08B | $1.47B |
| Net income | $474M | $905M | $894M | $793M | $857M |
| EPSd | $4.1M | $7.68M | $7.49M | $6.35M | $6.25M |
| Operating cash flow | $970M | $1.29B | $1.37B | $975M | $1.62B |
| Capital expenditure | -$-546M | -$-599M | -$-828M | -$-611M | -$-578M |
| Free cash flow | $424M | $688M | $546M | $364M | $1.04B |
| Total assets | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B |
| Total debt | $5.08B | $5.26B | $5.14B | $5.15B | $5.52B |
| Net debt | $4.51B | $4.42B | $4.59B | $4.66B | $5.06B |
| Total equity | $6.04B | $5.85B | $5.53B | $5.24B | $5.79B |
| Cash and short-term investments | $566M | $837M | $548M | $493M | $459M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $8.75B | $9.38B | $9.2B | $10.5B | $10.5B |
| Cost of revenue | $6.91B | $7.09B | $7.14B | $8.48B | $7.97B |
| Gross profit | $1.84B | $2.29B | $2.06B | $2.06B | $2.52B |
| Research and development expenses | $255M | $250M | $239M | $264M | $254M |
| Selling, general and administrative expenses | $658M | $664M | $727M | $708M | $795M |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $913M | $914M | $966M | $972M | $1.05B |
| Cost and expenses | $7.82B | $8.01B | $8.1B | $9.45B | $9.01B |
| Interest income | $0.00 | $16M | $10M | $6M | $3M |
| Interest expense | $208M | $216M | $225M | $188M | $192M |
| Depreciation and amortization | $513M | $509M | $498M | $477M | $538M |
| Ebitda | $1.29B | $1.8B | $1.81B | $1.64B | $1.81B |
| Operating income | $931M | $1.38B | $1.1B | $1.08B | $1.47B |
| Total other income/expenses, net | -$-363M | -$-298M | -$-9M | -$-107M | -$-387M |
| Income before tax | $568M | $1.08B | $1.09B | $977M | $1.08B |
| Income tax expense | $93M | $170M | $191M | $181M | $215M |
| Net income | $474M | $905M | $894M | $793M | $857M |
| Weighted average shares outstanding | $114.7M | $116.7M | $118.6M | $123.5M | $134.9M |
| Weighted average diluted shares outstanding | $115.6M | $117.9M | $119.4M | $124.9M | $137.1M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $566M | $837M | $548M | $493M | $459M |
| Net receivables | $999M | $1.17B | $1.15B | $1.28B | $1.58B |
| Inventory | $1.98B | $1.99B | $1.68B | $1.89B | $1.5B |
| Total current assets | $3.65B | $4.1B | $3.48B | $3.78B | $4.65B |
| Property, plant and equipment, net | $5.92B | $5.62B | $5.55B | $5.16B | $5B |
| Goodwill and intangible assets | $4.64B | $4.66B | $4.78B | $4.87B | $5B |
| Long-term investments | $111M | $186M | $124M | $183M | $145M |
| Total non-current assets | $11.2B | $11.1B | $11.2B | $10.9B | $10.9B |
| Total assets | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B |
| Accounts payable | $1.21B | $1.31B | $1.17B | $1.32B | $1.23B |
| Short-term debt | $642M | $499M | $593M | $1.13B | $797M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $2.65B | $2.71B | $2.58B | $3.25B | $2.97B |
| Long-term debt | $4.44B | $4.76B | $4.55B | $4.03B | $4.73B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $6.17B | $6.65B | $6.53B | $6.18B | $6.76B |
| Capital lease obligations | $117M | $96M | $120M | $0.00 | $157M |
| Total liabilities | $8.82B | $9.36B | $9.1B | $9.43B | $9.73B |
| Common stock | $2M | $2M | $2M | $2M | $2M |
| Retained earnings | $10.1B | $10B | $9.49B | $8.97B | $8.56B |
| Accumulated other comprehensive income (loss) | -$-160M | -$-314M | -$-319M | -$-205M | -$-182M |
| Total equity | $6.04B | $5.85B | $5.53B | $5.24B | $5.79B |
| Total investments | $111M | $186M | $124M | $183M | $145M |
| Total debt | $5.08B | $5.26B | $5.14B | $5.15B | $5.52B |
| Net debt | $4.51B | $4.42B | $4.59B | $4.66B | $5.06B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $474M | $908M | $896M | $796M | $867M |
| Depreciation and amortization | $513M | $509M | $498M | $477M | $538M |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-186M | -$-29M | $291M | $13M | -$-27M |
| Accounts receivable | $61M | $28M | $126M | $93M | -$-281M |
| Inventory | $24M | -$-344M | $201M | -$-430M | -$-389M |
| Accounts payable | -$-76M | $188M | -$-190M | $60M | $554M |
| Net cash provided by operating activities | $970M | $1.29B | $1.37B | $975M | $1.62B |
| Investments in property, plant and equipment | -$-546M | -$-599M | -$-828M | -$-611M | -$-555M |
| Acquisitions, net | $38M | $38M | $379M | $997M | $553M |
| Net cash used for investing activities | -$-462M | -$-534M | -$-432M | $392M | -$-29M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-100M | -$-300M | -$-150M | -$-1B | -$-1B |
| Dividends paid | -$-381M | -$-379M | -$-376M | -$-381M | -$-375M |
| Net cash used for financing activities | -$-797M | -$-454M | -$-888M | -$-1.32B | -$-1.69B |
| Net change in cash | -$-271M | $289M | $55M | $34M | -$-105M |
| Cash at end of period | $566M | $837M | $548M | $493M | $459M |
| Operating cash flow | $970M | $1.29B | $1.37B | $975M | $1.62B |
| Capital expenditure | -$-546M | -$-599M | -$-828M | -$-611M | -$-578M |
| Free cash flow | $424M | $688M | $546M | $364M | $1.04B |
Line items
Line items
Line items
About Eastman Chemical Company
Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators. Additional offerings include specialty coalescents, various commodity and specialty solvents, paint additives, specialty polymers, heat transfer and aviation fluids, and rubber additives such as insoluble sulfur and anti-degradants, along with performance resins. These products cater to diverse sectors such as transportation, personal care, wellness, food, agriculture, construction, water treatment, energy, consumables, durables, and electronics. The Advanced Materials segment produces high-performance products including copolyesters, cellulosic biopolymers, cellulose esters, and polyvinyl butyral (PVB) sheets. It further supplies a variety of window and protective films, including those applied aftermarket, for high-value applications in transportation, consumer durables, electronics, building and construction, medical, pharmaceutical, and general consumables markets. Through its Chemical Intermediates segment, Eastman delivers essential chemical building blocks. This encompasses methylamines and their salts, various higher amines and solvents, olefin and acetyl derivatives, ethylene, and both primary phthalate and non-phthalate plasticizers, including specialized non-phthalate alternatives. These intermediates are vital for industrial chemical processes, construction, health and wellness products, and agrochemical formulations. Lastly, the Fibers segment is a significant producer of cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride, primarily for filtration media, notably cigarette filters. It also furnishes natural and solution-dyed acetate yarns for consumables and health and wellness markets, alongside wet-laid nonwoven media, specialty engineered papers, and cellulose acetate fibers for the transportation, industrial, agriculture, mining, and aerospace industries. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.
- CEO
- Mark J. Costa
- Employees
- 13K
- Beta
- 1.08
Included in
Explore
Frequently asked questions
What is the intrinsic value of Eastman Chemical Company (EMN)?
Eastman Chemical Company (EMN) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is EMN undervalued?
EMN trades at a price of $58.77 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.